SummaryRasmussen encephalitis (RE) is a severe and progressive focal epilepsy of unknown origin that leads to deterioration of motor and cognitive function. In a previous study, we described positive effect of high doses of steroids during the first year after the onset of RE. The objective of this study was to evaluate this therapy at long term.We reviewed 11 patients (7 girls and 4 boys) with RE of the right hemisphere (7) and the left (4) at a follow-up of 9±2 years. Age at onset of RE ranged from 2 to 14 years.Six patients had no benefit from steroid therapy and underwent hemispherotomy. Five had significant reduction of seizure frequency with disappearance of epilepsia partialis continua, and improved motor function. Of these, two died...
OBJECTIVE: To verify safety and efficacy of the corticosteroid-sparing drug Azathioprine (AZA) in Ra...
Status epilepticus (SE) represents a neurological emergency that leads to considerable morbidity and...
Investigators from the National Epilepsy Center, Shizuoka, Gifu University, Tokyo Women’s Medical Un...
SummaryRasmussen encephalitis (RE) is a severe and progressive focal epilepsy of unknown origin that...
Rasmussen encephalitis (RE) is characterized by intractable epilepsy, progressive hemiparesis, and u...
AbstractPurposeTo describe the attributes of patients with Rasmussen's encephalitis (RE) seen in a t...
Rasmussen encephalitis (RE) is a rare but severe immune-mediated brain disorder leading to unilatera...
Rasmussen encephalitis (RE) is a rare but severe immune-mediated brain disorder leading to unilatera...
International audienceRasmussen's encephalitis (RE) is a severe, rare, chronic inflammatory brain di...
Rasmussen encephalitis is a chronic inflammatory disease commonly seen in children. Hemispheric atro...
AbstractPurposeThe aim of this study is to analyze the electroclinical features, treatment, and evol...
Rasmussen encephalitis (RE) is a chronic inflammatory disease leading to unilateral hemispheric atro...
Objective: Lennox-Gastaut syndrome (LGS) is a severe form of developmental and epileptic encephalopa...
Ten of 17 patients with Rasmussen’s syndrome receiving IV methylprednisolone and/or oral predisolone...
We present a case of posterior reversible encephalopathy syndrome with severe clinical manifestation...
OBJECTIVE: To verify safety and efficacy of the corticosteroid-sparing drug Azathioprine (AZA) in Ra...
Status epilepticus (SE) represents a neurological emergency that leads to considerable morbidity and...
Investigators from the National Epilepsy Center, Shizuoka, Gifu University, Tokyo Women’s Medical Un...
SummaryRasmussen encephalitis (RE) is a severe and progressive focal epilepsy of unknown origin that...
Rasmussen encephalitis (RE) is characterized by intractable epilepsy, progressive hemiparesis, and u...
AbstractPurposeTo describe the attributes of patients with Rasmussen's encephalitis (RE) seen in a t...
Rasmussen encephalitis (RE) is a rare but severe immune-mediated brain disorder leading to unilatera...
Rasmussen encephalitis (RE) is a rare but severe immune-mediated brain disorder leading to unilatera...
International audienceRasmussen's encephalitis (RE) is a severe, rare, chronic inflammatory brain di...
Rasmussen encephalitis is a chronic inflammatory disease commonly seen in children. Hemispheric atro...
AbstractPurposeThe aim of this study is to analyze the electroclinical features, treatment, and evol...
Rasmussen encephalitis (RE) is a chronic inflammatory disease leading to unilateral hemispheric atro...
Objective: Lennox-Gastaut syndrome (LGS) is a severe form of developmental and epileptic encephalopa...
Ten of 17 patients with Rasmussen’s syndrome receiving IV methylprednisolone and/or oral predisolone...
We present a case of posterior reversible encephalopathy syndrome with severe clinical manifestation...
OBJECTIVE: To verify safety and efficacy of the corticosteroid-sparing drug Azathioprine (AZA) in Ra...
Status epilepticus (SE) represents a neurological emergency that leads to considerable morbidity and...
Investigators from the National Epilepsy Center, Shizuoka, Gifu University, Tokyo Women’s Medical Un...